A new study has found that blocking the brain lymphatic vessels reduced MS-like illness in a laboratory model
A new study that suggests inflammation may lead to the death of brain cells in MS may have identified a drug that could block this process.
A study from MSIF McDonald fellow Dr Eshaghi has shown that brain tissue loss, or atrophy, occurs in ’stages’ and follows a predictable order.
New research suggests the rate of brain atrophy, or brain shrinkage, may be an important indicator of disease progression in MS.
Study reveals important mechanism that allows immune cells to attack myelin in MS
What’s behind the media reports on concussion and MS?